Tiziana Life Sciences (TLSA) Notes Payables (2018 - 2021)

Tiziana Life Sciences has reported Notes Payables for 4 years, with the latest figure at $1.4 million in Q4 2021.

• On a quarterly basis, Notes Payables fell 21.04% year-over-year to $1.4 million in Q4 2021; TTM through Dec 2021 was $1.4 million, a 21.04% decrease from a year earlier, with the FY2021 full-year figure at $1.4 million, down 21.04% from the prior year.
• Notes Payables was $1.4 million for Q4 2021 at Tiziana Life Sciences, down from $1.6 million in the prior quarter.
• The five-year high for Notes Payables was $1.7 million in Q4 2020, with the low at $401067.7 in Q2 2020.
• Average Notes Payables over 4 years is $942015.8, with a median of $579861.9 recorded in 2019.
• The sharpest annual moves came in 2020 and 2021: Notes Payables slipped 21.86% in 2020, then jumped 292.95% in 2021.
• Over 4 years, Notes Payables stood at $452942.1 in 2018, then rose by 28.02% to $579861.9 in 2019, then surged by 195.93% to $1.7 million in 2020, then decreased by 21.04% to $1.4 million in 2021.
• The last three Notes Payables figures came in at $1.4 million (Q4 2021), $1.6 million (Q2 2021), and $1.7 million (Q4 2020), per Business Quant data.